Result of sentinel lymph node biopsy using radioisotope in clinically lymph node negative breast cancer

被引:6
|
作者
Kim, Hee Jeong [1 ]
Chang, Mi Ae [1 ]
Hong, Soo Jeong [1 ]
Lee, Jung Sun [1 ]
Jung, Min Sung [1 ]
Kim, Mee Jung [2 ]
Gong, Gyung Yub [2 ]
Kim, Euy Nyong [3 ]
Kwak, Beom Seok [4 ]
Ahn, Sei Hyun [1 ]
Son, Byung Ho [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea
[4] Dong Guk Univ Int Hosp, Dept Surg, Seoul, South Korea
关键词
sentinel lymph node; early breast cancer; false negative rate;
D O I
10.4048/jbc.2007.10.2.141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Sentinel lymph node biopsy (SLNB) has been developed to accurately assess the axillary lymph node status accurately without having to remove most of the axillary contents in node negative early breast cancer patients. The aims of this study were to evaluate the accuracy, the false negative rate and the advantage of additional axillary sampling for SLNB with using radioisotope. Methods: Between December 2003 and June 2005, we carried out SLNB for 574 breast cancer patients who were diagnosed and had operation at Asan Medical Center. For detection of the sentinel lymph mode (SLN), radioisotope was injected into the periareolar area on the operating day, breast scintigraphy was performed and finally the biopsy was done using a gamma-detection probe in the operating room. If the SLN turned out to be positive for metastatic malignancy according to the frozen section histology, then additional axillary lymph nodes (LN) dissection was performed. But, if it was free of metastasis, then only axillary node sampling (n <= 5) or no further treatment was done. Results: The mean number of resected SLNs was 2.67 +/- 0.98 (1-7) and the mean number of total LN was 8.5 +/- 5.0 (1-38). The SLN was detected 82.8% of the time on lymphoscintigraphy and 98.4% of the time with the gamma probe. Axillary metastasis was founded in 118 cases (20.9%). The accuracy was 98.2%, and the false negative rate was 7.89%. For the SLN positive cases, there were 73/78 cases (93.6%) of list SLN metastasis, there were 75/78 cases (93.6%) of 1st and 2nd SLN metastasis, and 75178 (93.6%) of 1 st to 3rd SLN metastasis. The false negative rate of the alternative frozen section was 40% and that of the full frozen section was 24.1%. The difference was statistically significant. Conclusion: SLNB using Tc-99m-antimony trisulfide colloid (0.5 mCi) showed a high detection rate and a low false negative rate. The false negative rate was decreased by using full section H&E staining and at least 3 SLNs showed the exact LN status. Even if the SLN was free of metastasis, additional sampling may decrease the false negative rate.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 50 条
  • [41] Predictive value of sentinel lymph node biopsy prior to neoadjuvant chemotherapy in clinically node negative breast cancer.
    Jones, JL
    Rhei, E
    Gadd, MA
    Howard-Mcnatt, M
    Hughes, KS
    Lesnikoski, BA
    Christian, RL
    Rabban, JT
    Kaelin, C
    Smith, BL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 28S - 28S
  • [42] Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Response to Letter]
    AlSumai, Thuraya S.
    Alhefdhi, Amal
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 133 - 134
  • [43] Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
    Matar-Ujvary, Regina
    Sevilimedu, Varadan
    Morrow, Monica
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
  • [44] Sentinel lymph node biopsy in patients with recurrent breast cancer and previous negative sentiel lymph node biopsy: our experience
    Reyes, J.
    Lazaro, M. Bajen
    Benitez-Segura, A.
    Sanz, B. Hervas
    Lozano, C. Soldevila
    Pudis, M.
    Bondia, S.
    Ramon, J. Suils
    Salvado, J. Mora
    Ortiz, A. Valdivieso
    Tapia, L. Perez
    Vicente, M.
    Farnos, M. Pla
    Tejedor, A. Garcia
    Delgado, M. Campos
    Montoli, M. Fernandez
    Petit, A.
    Pernas, S.
    Catalina, F.
    Perez, E. Martinez
    Montero, H. Perez
    Ojeda, A. Lopez
    Sidelnikova, D. Perez
    Gonzalez, S. De la Torre
    Romera, M. Cortes
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S533 - S533
  • [45] Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
    Matar-Ujvary, Regina
    Sevilimedu, Varadan
    Morrow, Monica
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S87 - S87
  • [46] Breast and sentinel lymph node biopsy
    不详
    [J]. AORN JOURNAL, 2019, 110 (04) : P14 - P16
  • [47] Intraoperative Radioisotope Injection for Sentinel Lymph Node Biopsy
    Thompson, Margaret
    Korourian, Soheila
    Henry-Tillman, Ronda
    Adkins, Laura
    Mumford, Sheilah
    Smith, Maureen
    Klimberg, V. Suzanne
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) : 3216 - 3221
  • [48] Intraoperative Radioisotope Injection for Sentinel Lymph Node Biopsy
    Margaret Thompson
    Soheila Korourian
    Ronda Henry-Tillman
    Laura Adkins
    Sheilah Mumford
    Maureen Smith
    V. Suzanne Klimberg
    [J]. Annals of Surgical Oncology, 2008, 15 : 3216 - 3221
  • [49] Sentinel lymph node biopsy in clinically node negative patients with papillary thyroid carcinoma
    Markovic, Ivan
    Goran, Merima
    Buta, Marko
    Stojiljkovic, Dejan
    Zegarac, Milan
    Milovanovic, Zorka
    Dzodic, Radan
    [J]. JOURNAL OF BUON, 2020, 25 (01): : 376 - 382
  • [50] Update - Sentinel lymph node biopsy for breast cancer
    Bold, RJ
    Schlieman, M
    Fahy, BN
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (05) : 347 - 357